Overview

Prophylactic Administration of Levosimendan in Patients Undergoing Coronary Surgery

Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The present pilot study aims to investigate the effectiveness of the preoperative infusion of levosimendan in patients with impaired left ventricular function undergoing coronary artery bypass grafting.
Phase:
Phase 4
Details
Lead Sponsor:
AHEPA University Hospital
Collaborator:
Orion Corporation, Orion Pharma
Treatments:
Simendan